# Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients

> **NCT01783834** · PHASE2 · COMPLETED · sponsor: **Gachon University Gil Medical Center** · enrollment: 95 (actual)

## Conditions studied

- Previous Treated Metastatic Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Gefitinib
- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT01783834
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783834, "Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01783834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*